Authors
  • Dr. Kearon trained as a respirologist and obtained a Ph.D. from McMaster University for studies relating to respiratory and exercise physiology. His clinical work now focuses on thromboembolic diseases. He is a Professor in the Department of Medicine, an Associated Member in the Department of Health Research Methods, Evidence, and Impact at McMaster University, a Career Investigator of the Heart and Stroke Foundation of Ontario, and holds the Jack Hirsh Professorship in Thromboembolism at McMaster University. He was has received awards from the Canadian Institutes of Health Research for providing mentorship in the design and conduct of randomized controlled trials, and the International Society on Thrombosis and Haemostasis’ 14th Biennial Investigator Recognition Award. He has authored or co-authored over 200 peer-reviewed publications.

    Dr. Kearon's research focuses on clinical trials designed to optimize the diagnosis and treatment of venous thromboembolic disease. The Heart and Stroke Foundation of Ontario (HSFO), the Canadian Institutes of Health Research (CIHR), the National Institutes of Health (NIH), and the Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) group support Dr. Kearon’s research. He is lead author of the past three editions of American College of Chest Physicians’ CHEST guidelines for the treatment of venous thromboembolism.

    • Emergency Medicine
    • Internal Medicine

    I am an Assistant Professor in McMaster University, and work clinically in both emergency medicine and thrombosis medicine. I trained in internal medicine and emergency medicine in the UK, and completed a Thrombosis fellowship in Ottawa in 2013. I have two postgraduate research degrees and focus my current research on diagnosis of pulmonary embolism and diagnosis of bleeding within the emergency department.

    • Assistant Professor in the Departments of Oncology, and Health Research Methods, Evidence, and Impact at McMaster University

    Sameer Parpia is a biostatistician and Assistant Professor in the Departments of Oncology, and Health Research Methods, Evidence, and Impact at McMaster University. He received his PhD in Health Research Methods (Biostatistics) in the department of Clinical Epidemiology & Biostatistics at McMaster University.

    Dr. Parpia’s research focuses on clinical trials in the areas of oncology and venous thromboembolism. He is currently the lead statistician on several trials that are funded by the Canadian Institutes of Health Research (CIHR), the National Institutes of Health (NIH) and the Canadian Cancer Society Research Institute (CCSRI).

Powered by Medstro